Cyclin E1 (CCNE1) as independent positive prognostic factor in advanced stage serous ovarian cancer patients-A study of the OVCAD consortium

European Journal of Cancer

Volumn 50, Issue 1, 2014, Pages 99-110

  Pils, Dietmar ^a   Bachmayr Heyda, Anna ^a   Auer, Katharina ^a   Svoboda, Martin ^b   Auner, Veronika ^a   Hager, Gudrun ^a   Obermayr, Eva ^a,c   Reiner, Angelika ^d   Reinthaller, Alexander ^a   Speiser, Paul ^a   Braicu, Ioana ^e   Sehouli, Jalid ^e   Lambrechts, Sandrina ^f   Vergote, Ignace ^f   Mahner, Sven ^g   Berger, Astrid ^h   Cacsire Castillo Tong, Dan ^a   Zeillinger, Robert ^a,c  

^a UNIV KLIN FÜR FRAUENHEILKUNDE   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

^d DANUBE HOSPITAL   (Austria)

^e CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^f UNIVERSITY OF LEUVEN   (Belgium)

^g MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^h INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

CCNE1; Molecular subclass; Ovarian cancer; Prognosis; Proliferation

Indexed keywords

CYCLIN E; CYCLIN E1; CYCLIN E2; TRANSCRIPTOME; UNCLASSIFIED DRUG;

ADULT; ADVANCED CANCER; ARTICLE; CANCER CLASSIFICATION; CANCER GRADING; CANCER PATIENT; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CANCER TISSUE; CARCINOMATOUS PERITONITIS; CELL CYCLE; CONTROLLED STUDY; DOWN REGULATION; FANCONI ANEMIA; FEMALE; GENE DOSAGE; GENE EXPRESSION; GENETIC ANALYSIS; GENOME ANALYSIS; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MICROARRAY ANALYSIS; MIDDLE AGED; MINIMAL RESIDUAL DISEASE; OUTCOME ASSESSMENT; OVARY CARCINOMA; OVERALL SURVIVAL; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION; VIRUS CARCINOGENESIS;

CCNE1; MOLECULAR SUBCLASS; OVARIAN CANCER; PROGNOSIS; PROLIFERATION;

CELL PROLIFERATION; CYCLIN E; CYCLINS; FEMALE; GENE AMPLIFICATION; GENE DOSAGE; GENE EXPRESSION; HUMANS; MIDDLE AGED; NEOPLASMS, GLANDULAR AND EPITHELIAL; ONCOGENE PROTEINS; OVARIAN NEOPLASMS; PROGNOSIS; SIGNAL TRANSDUCTION; TUMOR MARKERS, BIOLOGICAL;

EID: 84891635542     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2013.09.011     Document Type: Article

References (47)

1. A. Jemal, R. Siegel, E. Ward, Y. Hao, J. Xu, and M.J. Thun Cancer statistics, 2009 CA Cancer J Clin 59 4 2009 225 249
2. P. de Graeff, A.P. Crijns, S. de Jong, M. Boezen, W.J. Post, and E.G. de Vries et al. Modest effect of p53, EGFR and HER-2/neu on prognosis in epithelial ovarian cancer: a meta-analysis Br J Cancer 101 1 2009 149 159
3. R. Brosh, and V. Rotter Transcriptional control of the proliferation cluster by the tumor suppressor p53 Mol Biosyst 6 1 2010 17 29
4. S. Mandal, W.A. Freije, P. Guptan, and U. Banerjee Metabolic control of G1-S transition: cyclin E degradation by p53-induced activation of the ubiquitin-proteasome system J Cell Biol 188 4 2010 473 479
5. M. Malumbres, and M. Barbacid Cell cycle, CDKs and cancer: a changing paradigm Nat Rev Cancer 9 3 2009 153 166
6. A. Satyanarayana, and P. Kaldis Mammalian cell-cycle regulation: several Cdks, numerous cyclins and diverse compensatory mechanisms Oncogene 28 33 2009 2925 2939
7. J.K. Kim, and J.A. Diehl Nuclear cyclin D1: an oncogenic driver in human cancer J Cell Physiol 220 2 2009 292 296
8. E.J. Nam, and Y.T. Kim Alteration of cell-cycle regulation in epithelial ovarian cancer Int J Gynecol Cancer 18 6 2008 1169 1182
9. L. Sui, Y. Dong, M. Ohno, K. Sugimoto, Y. Tai, and T. Hando et al. Implication of malignancy and prognosis of p27(kip1), Cyclin E, and Cdk2 expression in epithelial ovarian tumors Gynecol Oncol 83 1 2001 56 63
10. E. Rosenberg, R.I. Demopoulos, A. Zeleniuch-Jacquotte, H. Yee, J. Sorich, and J.L. Speyer et al. Expression of cell cycle regulators p57(KIP2), cyclin D1, and cyclin E in epithelial ovarian tumors and survival Hum Pathol 32 8 2001 808 813
11. D.G. Rosen, G. Yang, M.T. Deavers, A. Malpica, J.J. Kavanagh, and G.B. Mills et al. Cyclin E expression is correlated with tumor progression and predicts a poor prognosis in patients with ovarian carcinoma Cancer 106 9 2006 1925 1932
12. J. Farley, L.M. Smith, K.M. Darcy, E. Sobel, D. O'Connor, and B. Henderson et al. Cyclin E expression is a significant predictor of survival in advanced, suboptimally debulked ovarian epithelial cancers: a Gynecologic Oncology Group study Cancer Res 63 6 2003 1235 1241
13. A. Koff, F. Cross, A. Fisher, J. Schumacher, K. Leguellec, and M. Philippe et al. Human cyclin E, a new cyclin that interacts with two members of the CDC2 gene family Cell 66 6 1991 1217 1228
14. M. Zariwala, J. Liu, and Y. Xiong Cyclin E2, a novel human G1 cyclin and activating partner of CDK2 and CDK3, is induced by viral oncoproteins Oncogene 17 21 1998 2787 2798
15. D. Etemadmoghadam, A. de Fazio, R. Beroukhim, C. Mermel, J. George, and G. Getz et al. Integrated genome-wide DNA copy number and expression analysis identifies distinct mechanisms of primary chemoresistance in ovarian carcinomas Clin Cancer Res 15 4 2009 1417 1427
16. Y. Patael-Karasik, M. Daniely, W.H. Gotlieb, G. Ben-Baruch, J. Schiby, and G. Barakai et al. Comparative genomic hybridization in inherited and sporadic ovarian tumors in Israel Cancer Genet Cytogenet 121 1 2000 26 32
17. R. Chekerov, I. Braicu, D.C. Castillo-Tong, R. Richter, I. Cadron, and S. Mahner et al. Outcome and clinical management of 275 patients with advanced ovarian cancer International Federation of Obstetrics and Gynecology II to IV inside the European Ovarian Cancer Translational Research Consortium-OVCAD Int J Gynecol Cancer 23 2 2013 268 275
18. Classification and staging of malignant tumours in the female pelvis. Acta Obstet Gynecol Scand 1971;50(1):1-7.
19. K. Yoshihara, A. Tajima, D. Komata, T. Yamamoto, S. Kodama, and H. Fujiwara et al. Gene expression profiling of advanced-stage serous ovarian cancers distinguishes novel subclasses and implicates ZEB2 in tumor progression and prognosis Cancer Sci 100 8 2009 1421 1428
20. D. Pils, G. Hager, D. Tong, S. Aust, G. Heinze, and M. Kohl et al. Validating the impact of a molecular subtype in ovarian cancer on outcomes: a study of the OVCAD Consortium Cancer Sci 103 2012 1334 1341
21. J. Vandesompele, K. De Preter, F. Pattyn, B. Poppe, N. Van Roy, and A. De Paepe et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes Genome Biol 3 7 2002 RESEARCH0034
22. R Core Team. R: a language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing; 2012. 〈http://www.R-project.org/〉.
23. V.G. Tusher, R. Tibshirani, and G. Chu Significance analysis of microarrays applied to the ionizing radiation response Proc Natl Acad Sci USA 98 9 2001 5116 5121
24. P. Royston, and W. Sauerbrei Multivariable model-building: a pragmatic approach to regression analysis based on fractional polynomials for modelling continuous variables 2008 John Wiley
25. G.K. Smyth Limma: linear models for microarray data R. Gentleman, V. Carey, W. Huber, R. Irizarry, S. Dudoit, Bioinformatics and computational biology solutions using R and bioconductor 2005 Springer New York 397 420
26. P. Kampstra Beanplot: a boxplot alternative for visual comparison of distributions J Stat Softw 28 2008 1 9
27. A.L. Tarca, S. Draghici, P. Khatri, S.S. Hassan, P. Mittal, and J.S. Kim et al. A novel signaling pathway impact analysis Bioinformatics 25 1 2009 75 82
28. D. Beisser, G.W. Klau, T. Dandekar, T. Muller, and M.T. Dittrich BioNet: an R-package for the functional analysis of biological networks Bioinformatics 26 8 2010 1129 1130
29. M. Aluru, J. Zola, D. Nettleton, and S. Aluru Reverse engineering and analysis of large genome-scale gene networks Nucleic Acids Res 41 1 2013 e24
30. M.E. Smoot, K. Ono, J. Ruscheinski, P.L. Wang, and T. Ideker Cytoscape 2.8: new features for data integration and network visualization Bioinformatics 27 3 2011 431 432
31. M. Krzywinski, I. Birol, S.J. Jones, and M.A. Marra Hive plots-rational approach to visualizing networks Brief Bioinform 13 5 2012 627 644
32. L. Li, S. Ryser, E. Dizin, D. Pils, M. Krainer, and C.E. Jefford et al. Oncogenic BARD1 isoforms expressed in gynecological cancers Cancer Res 67 24 2007 11876 11885
33. M.H. Yun, and K. Hiom Understanding the functions of BRCA1 in the DNA-damage response Biochem Soc Trans 37 Pt 3 2009 597 604
34. D.C. Porter, E. Farmaki, S. Altilia, G.P. Schools, D.K. West, and M. Chen et al. Cyclin-dependent kinase 8 mediates chemotherapy-induced tumor-promoting paracrine activities Proc Natl Acad Sci USA 109 34 2012 13799 13804
35. D. Yang, Y. Sun, L. Hu, H. Zheng, P. Ji, and C.V. Pecot et al. Integrated analyses identify a master MicroRNA regulatory network for the mesenchymal subtype in serous ovarian cancer Cancer Cell 23 2 2013 186 199
36. D.X. Peng, M. Luo, L.W. Qiu, Y.L. He, and X.F. Wang Prognostic implications of microRNA-100 and its functional roles in human epithelial ovarian cancer Oncol Rep 27 4 2012 1238 1244
37. A. Malpica, M.T. Deavers, K. Lu, D.C. Bodurka, E.N. Atkinson, and D.M. Gershenson et al. Grading ovarian serous carcinoma using a two-tier system Am J Surg Pathol 28 4 2004 496 504
38. A. Malpica, M.T. Deavers, C. Tornos, R.J. Kurman, R. Soslow, and J.D. Seidman et al. Interobserver and intraobserver variability of a two-tier system for grading ovarian serous carcinoma Am J Surg Pathol 31 8 2007 1168 1174
39. Y.H. Lee, J.H. Heo, T.H. Kim, H. Kang, G. Kim, and J. Kim et al. Significance of cell cycle regulatory proteins as malignant and prognostic biomarkers in ovarian epithelial tumors Int J Gynecol Pathol 30 3 2011 205 217
40. M.C. Heeran, C.K. Hogdall, S.K. Kjaer, L. Christensen, J. Blaakaer, and I.J. Christensen et al. Limited prognostic value of tissue protein expression levels of cyclin E in Danish ovarian cancer patients: from the Danish 'MALOVA' ovarian cancer study APMIS 120 10 2012 846 854
41. K. Keyomarsi, S.L. Tucker, T.A. Buchholz, M. Callister, Y. Ding, and G.N. Hortobagyi et al. Cyclin E and survival in patients with breast cancer N Engl J Med 347 20 2002 1566 1575
42. K. Milde-Langosch, M. Hagen, A.M. Bamberger, and T. Loning Expression and prognostic value of the cell-cycle regulatory proteins, Rb, p16MTS1, p21WAF1, p27KIP1, cyclin E, and cyclin D2, in ovarian cancer Int J Gynecol Pathol 22 2 2003 168 174
43. S. Aust, A. Bachmayr-Heyda, P. Pateisky, D. Tong, S. Darb-Esfahani, and C. Denkert et al. Role of TRAP1 and estrogen receptor alpha in patients with ovarian cancer-A study of the OVCAD consortium Mol Cancer 11 2012 69
44. K.P. Magnusson, R. Satalino, W. Qian, G. Klein, and K.G. Wiman Is conversion of solid into more anoxic ascites tumors associated with p53 inactivation? Oncogene 17 18 1998 2333 2337
45. K.S. Kim, S. Sengupta, M. Berk, Y.G. Kwak, P.F. Escobar, and J. Belinson et al. Hypoxia enhances lysophosphatidic acid responsiveness in ovarian cancer cells and lysophosphatidic acid induces ovarian tumor metastasis in vivo Cancer Res 66 16 2006 7983 7990
46. E.C. Kohn, and J. Hurteau Ovarian cancer: making its own rules-again Cancer 119 3 2013 474 476
47. A. Bachmayr-Heyda, G. Aust, S. Heinze, S. Polterauer, C. Grimm, and E.I. Braicu et al. Prognostic impact of tumor infiltrating CD8+ T cells in association with cell proliferation in ovarian cancer patients-a study of the OVCAD consortium BMC Cancer 13 1 2013 422